6th Annual ALS ONE Research Symposium: Day 2 Industry Speaker: Bob Dagher, MD, of Brainstorm-Cell.

ALS ONE's 6th Annual ALS ONE Research Symposium, held November 16, 17, and 20, 2023, hosted by our research team: Dr’s Merit Cudkowicz, MD, MSc of MGH, Robert H Brown, Jr. MD, DPhil of UMass Medical School, James Berry, MD, MPH of MGH, Sabrina Paganoni, MD, PhD of MGH, and Fernando Vieira, MD of ALS TDI, and in collaboration with Indu Navar, Dr. Shel Lalji, Dr. Leigh Hochberg, and Blair Casey of Team Gleason for Day 3's Neurotechnology Day. The conference had over 865 registered guests from 37 countries, including researchers, scientists, and members of the ALS community from around the world, convening virtually for 3 days of sharing critical research that is underway across the globe to help uncover therapeutic options leading to an ultimate cure for Amyotrophic Lateral Sclerosis (ALS). Recordings were made of the presentations which we are/were approved to share.

IN THIS VIDEO: Symposium Segment: ALS Industry Speakers
Presentation Title: Biomarker exploration of NurOwn’s multimodal mechanism of action on neuroinflammation, neuroprotection and neurodegeneration.
Speaker: Bob Dagher, MD, President and Chief Development Officer at Brainstorm Cell Therapeutics.
Moderator: Dr. Fernando Vieira, MD